Israeli supplier, Frutarom, has had a patent validated by the European Patent Office (EPO) for the soy isoflavone forms, genistein and daidzein. The patent allows for products containing between 20 and 200mg of the isoflavones that are typically used to mediate menopausal conditions such as rashes and hot flushes as well as premenstrual syndrome. Frutarom [...]
Tag Archives | patent
Recent Posts
- Safety aspects of soyfoods and soy isoflavones in men
- Safety of Frutarom`s daidzein rich SoyLife products
- SoyLife Overview
- Soylife, Calcium and Vit D in the prevention of osteoporosis – OPUS study 2004–2007
- SoyLife® Extra
- Soy isoflavone supplementation enhances spatial working memory in Men
- Safety evaluation of SoyLife
- Various doses of soy isoflavones do not modify mammographic density in postmenopausal women
- Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors
- Estrogenic activity of glycitein, a soy isoflavone


